Investigators have developed a prognostic model that may identify which patients with MIBC are suitable for bladder-preserving chemoradiation.
Stage 2 cervical cancer is classified into 2A and 2B, based on tumor spread and size, affecting treatment decisions.
Stage 2 oral cavity cancer involves tumors larger than 2 cm but not exceeding 4 cm, without lymph node or distant spread. Diagnosis includes physical exams, biopsies, imaging tests, and endoscopy to ...
Experts explore the messy intersection between evidence-based cancer care and an enticing wellness industry dominated by ...
Tiragolumab plus atezolizumab does not improve survival compared to durvalumab in locally advanced, unresectable, stage 3 NSCLC.
Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, ...
The American Society for Radiation Oncology (ASTRO) recently announced the three winning research proposals for the 2025 ASTRO-AstraZeneca Small Cell Lung Cancer (SCLC) Therapy Challenge, which ...
THOUSAND OAKS, Calif., Nov. 4, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2025.
Artificial neural networks predicted overall and progression-free survival after chemoradiation in older adults with head and ...
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each ...
In August 2025, AbbVie organized a study is to assess adverse events and change in disease activity when Telisotuzumab ...
Graham joined the News 9 team in February of 2025. He is dedicated to sharing the diverse stories that have shaped his country and his community.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results